# Coagulation-inflammation crosstalk in placental abruption > **NIH NIH R01** · MEDICAL COLLEGE OF WISCONSIN · 2024 · $587,641 ## Abstract PROJECT SUMMARY/ABSTRACT: Placental abruption is a life-threatening pregnancy complication where the placenta completely or partially separates from the uterus before the birth of the baby. Abruption complicates 1 to 2% of all births; two-thirds are classified as severe based on associated maternal and perinatal morbidity and mortality. Numerous studies suggest that abruption is a culmination of early ischemic pathology involving blood coagulation and inflammation. However, disease onset and mechanisms involved in its progression into abruption are poorly understood and constitute an important gap in knowledge. A well-recognized barrier is that human placental tissue cannot be obtained until pregnancy is over, making early pathology and its progression challenging to investigate. Our preliminary data demonstrate that mice deficient in Endothelial Protein C Receptor (EPCR), an endogenous inhibitor of blood coagulation, exhibit decidual blood clots that progress into placental abruption. We have discovered that this process requires thrombin receptor Par4 and is accompanied by infiltration of leukocytes and evidence of their acute inflammatory reaction involving (1) release of myeloperoxidase (MPO), an enzyme that generates toxic oxidants, and (2) histone citrullination, a posttranslational modification of histones that changes chromatin structure and drives inflammation. Importantly, our data shows that MPO- release and citrullination of histones also occur in human placental abruption, supporting the relevance of our findings. Taken together, these new findings suggest that activation of the blood clotting cascade results in recruitment of immune cells to the decidua, and that their ensuing inflammatory response mediates placental abruption. The long-term goal of this research is to identify cellular and molecular components of this coagulation-inflammation crosstalk in the setting of maternal thrombophilia, and to identify potential therapeutic targets to inhibit progression into placental abruption. The objective of this application is to test the hypothesis that onset of decidual blood clots and progression into placental abruption requires thrombin receptor activation, recruitment of MPO-expressing leukocytes and activation of their downstream mechanism of injury. Specific aim 1 will identify and phenotype altered immune cell populations in the decidua, and their trafficking to and from the decidua during onset and development of placental abruption. Specific aim 2 will dissect the roles of coagulation components and the vascular endothelium in onset and progression to placental abruption. Specific aim 3 will identify mediators of inflammation in the pathogenesis of placental abruption with particular emphasis on the roles of neutrophils and MPO, and their destructive cycle of oxidative stress and chronic inflammation. The expected outcome is a comprehensive understanding of immune cells that are recruited to the decidua in the context of act... ## Key facts - **NIH application ID:** 10909023 - **Project number:** 5R01HL163623-02 - **Recipient organization:** MEDICAL COLLEGE OF WISCONSIN - **Principal Investigator:** Rashmi Sood - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2024 - **Award amount:** $587,641 - **Award type:** 5 - **Project period:** 2023-08-20 → 2027-07-31 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10909023 ## Citation > US National Institutes of Health, RePORTER application 10909023, Coagulation-inflammation crosstalk in placental abruption (5R01HL163623-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10909023. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*